VYNE Therapeutics Inc. 10-Q and 10-Q/A reports

Location
685 Route 202/206 N., Suite 301, Bridgewater, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:10 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q May 9, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 13, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 14, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 14, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 12, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 12, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 10, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 12, 2021 Jun 30, 2021
10-Q Report | Data 10-Q May 6, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Nov 5, 2020 Sep 30, 2020
10-Q Report | Data 10-Q Aug 6, 2020 Jun 30, 2020
10-Q Report | Data FORM 10-Q May 11, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Oct 31, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 1, 2019 Jun 30, 2019
10-Q Report | Data 10-Q May 2, 2019 Mar 31, 2019
10-Q Report | Data 10-Q Nov 7, 2018 Sep 30, 2018
10-Q Report | Data 10-Q Aug 1, 2018 Jun 30, 2018
10-Q Report | Data 10-Q May 9, 2018 Mar 31, 2018